Healthcare Technology Featured Article

June 16, 2011

Watermark to Offer NOX-T3 Home Sleep Testing Device by CareFusion

Watermark Medical, Inc., will offer the NOX-T3 Home Sleep Testing (HST) device by CareFusion, a leading, global medical technology company which shares Watermark Medical’s mission to diagnose chronic disease patients who suffer the effects of obstructive sleep apnea (OSA).

NOX-T3 portable sleep monitor will be available through Watermark Medical’s network in Q3 2011. Featuring an array of sleep sensors, NOX-T3 offers a second HST option for patients, in addition to ARES, a physiological recorder used to monitor and store up to three nights of nocturnal data, measuring, among other factors, blood oxygen saturation, airflow, pulse rate and snoring levels.

 “We are excited to add another HST option to our current offering,” said Charlie Alvarez, president of Watermark Medical, in a statement. “As OSA awareness increases and insurance companies are mandating a home sleep test option, availability of the CareFusion NOX-T3 home sleep testing device allows us to further expand the Watermark Medical platform and allow other HST devices to access our extensive physician, sleep lab and DME networks."

 “We are focused on providing products to assist undiagnosed sleep apnea patients, and this agreement with Watermark Medical will broaden the awareness and diagnosis of sleep disordered breathing across the U.S.,” said Gijsbert Van Kampen, vice president of marketing, Respiratory Care at CareFusion.

Watermark Medical is known for offering the first and only automated end-to-end service for the diagnosis and treatment of sleep breathing disorders through their web-based health IT platform, utilizing the ARES an FDA-cleared, state-of-the-art, wireless home sleep test device. The company recently announced the completion of a $6 million equity investment from Ballast Point Ventures. Ballast Point Ventures will hold a minority stake in Watermark Medical and one seat on Watermark's Board of Directors along with CA Technologies (NASDAQ: CA), who led the round with a $15 million dollar investment earlier this year.

Rahul Arora is a HealthTechZone contributor. He has worked as an editor and freelance writer for several reputed organizations in India. To read more of his articles, please visit his columnist page.

Edited by Rich Steeves

Get stories like this delivered straight to your inbox. [Free eNews Subscription]


FREE eNewsletter

Click here to receive your targeted Healthcare Technology Community eNewsletter.
[Subscribe Now]